Literature DB >> 19918708

[Malignant hyperthermia--diagnostics, treatment and anaesthetic management].

Frank Schuster1, Clemens R Müller-Reible.   

Abstract

In malignant hyperthermia (MH) susceptible individuals volatile anaesthetics and the depolarizing muscle relaxant succinylcholine may induce a potentially lethal hypermetabolic syndrome of skeletal muscle due to an uncontrolled sarcoplasmic calcium release. Immediate discontinuation of triggering agents, oxygenation, correction of acidosis and electrolyte abnormalities and dantrolene application are essential for MH treatment. This article reviews the clinical symptoms of MH, the diagnostic criteria and the actual guidelines for treatment and management of anaesthesia in susceptible individuals. (c) Georg Thieme Verlag KG Stuttgart-New York.

Entities:  

Mesh:

Year:  2009        PMID: 19918708     DOI: 10.1055/s-0029-1242125

Source DB:  PubMed          Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther        ISSN: 0939-2661            Impact factor:   0.698


  7 in total

1.  [Hotline for malignant hyperthermia. New telephone number for the German nationwide 24 h service center: 08221/9600].

Authors:  W Klingler; F Lehmann-Horn; U Schulte-Sasse
Journal:  Anaesthesist       Date:  2011-02       Impact factor: 1.041

Review 2.  [Malignant hyperthermia].

Authors:  T Metterlein; F Schuster; B M Graf; M Anetseder
Journal:  Anaesthesist       Date:  2014-12       Impact factor: 1.041

3.  The effect of succinylcholine on malignant hyperthermia events in susceptible swine.

Authors:  Frank Schuster; Stephan Johannsen; Susanne Moegele; Thomas Metterlein; Norbert Roewer; Martin Anetseder
Journal:  BMC Anesthesiol       Date:  2014-03-07       Impact factor: 2.217

4.  A minimal-invasive metabolic test detects malignant hyperthermia susceptibility in a patient after sevoflurane-induced metabolic crisis.

Authors:  Frank Schuster; Stephan Johannsen; Norbert Roewer; Martin Anetseder
Journal:  Case Rep Anesthesiol       Date:  2013-12-26

5.  Evaluation of suspected malignant hyperthermia events during anesthesia.

Authors:  Frank Schuster; Stephan Johannsen; Daniel Schneiderbanger; Norbert Roewer
Journal:  BMC Anesthesiol       Date:  2013-09-23       Impact factor: 2.217

Review 6.  Management of malignant hyperthermia: diagnosis and treatment.

Authors:  Daniel Schneiderbanger; Stephan Johannsen; Norbert Roewer; Frank Schuster
Journal:  Ther Clin Risk Manag       Date:  2014-05-14       Impact factor: 2.423

7.  Malignant hyperthermia in the intensive care setting.

Authors:  Frank Schuster; Susanne Moegele; Stephan Johannsen; Norbert Roewer
Journal:  Crit Care       Date:  2014-02-26       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.